Partner with us

Get your ticket

Call to action

Your text goes here. Insert your content, thoughts, or information in this space.

Button

Back to speakers

Russell

Hanson

Chief Innovation Officer

Sama Therapeutics

Russell Hanson is a scientist and executive at the intersection of AI, healthcare, and biotechnology. As Chief Innovation Officer at Sama Therapeutics, he leads iMAGiNE, a GenAI platform for neuropsychiatry that supports drug discovery, diagnostics, and clinical decision-making. He has co-founded multiple AI and biotech companies, overseen successful exits, and advised on $100M+ transactions. Russell’s work spans AI drug discovery, neurodegenerative diseases, biosensors, and more, with publications in top scientific journals. A frequent keynote speaker, his mission is to harness AI, chemistry, and synthetic biology to drive global health innovation and improve patient outcomes through data-driven, validated technologies.

Button

31 July 2025 10:45 - 11:30

Panel | Beyond the hype: What AIOps can actually automate today

AIOps promises end-to-end automation, but the real question is what it can actually handle in production. This session cuts past the marketing and focuses on the workflows teams are automating right now and where human oversight still matters. We’ll break down the capabilities that are mature today (noise reduction, anomaly detection, incident routing, change risk scoring), the limits teams keep hitting, and how to judge whether a task is safe to automate. Key takeaways: → What’s truly ready for automation. → Where human validation is still essential. → How to avoid the common traps of over-automation.